L. Mawhinney

Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis

A. Bowie, D. Shields, S. Kunkel, 2018, QJM : monthly journal of the Association of Physicians.

Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit Pseudomonas aeruginosa-induced inflammation and biofilm formation.

A. Prina‐Mello, Y. Volkov, M. Doroudian, 2020, Nanomedicine.

Inflammation and cancer: macrophage migration inhibitory factor (MIF)—the potential missing link

S. Donnelly, H. Conroy, L. Mawhinney, 2010, QJM : monthly journal of the Association of Physicians.

Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities

M. Doroudian, S. Donnelly, L. Mawhinney, 2016, Medicinal research reviews.

Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer

L. Leng, G. Fingerle-Rowson, R. Bucala, 2014, Molecular medicine.

Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis

J. Bernhagen, L. Leng, R. Bucala, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.